Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury
about
Proteomic analysis of lung tissue in a rat acute lung injury model: identification of PRDX1 as a promoter of inflammationComparative Proteomic Analysis of Rat Bronchoalveolar Lavage Fluid after Exposure to Zinc Oxide NanoparticlesMast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammationRegulation of ozone-induced lung inflammation and injury by the β-galactoside-binding lectin galectin-3.Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsisThe proteome of Hypobaric Induced Hypoxic Lung: Insights from Temporal Proteomic Profiling for Biomarker DiscoveryTrace Levels of Staphylococcal Enterotoxin Bioactivity Are Concealed in a Mucosal Niche during Pulmonary Inflammation.RKIP contributes to IFN-γ synthesis by CD8+ T cells after serial TCR triggering in systemic inflammatory response syndromeBiomarkers of lung injury in critical care medicine: past, present, and future.Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approach.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor.Editor's Highlight: CCR2 Regulates Inflammatory Cell Accumulation in the Lung and Tissue Injury following Ozone Exposure.TNF and CD28 Signaling Play Unique but Complementary Roles in the Systemic Recruitment of Innate Immune Cells after Staphylococcus aureus Enterotoxin A Inhalation.Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide.Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.
P2860
Q21284702-4206EAC2-48AE-47B4-9617-3878A58CC10EQ33738108-CD1EA2A1-4C8D-414F-BD47-ED0CA9347112Q35014406-D3ADF807-3634-44F6-9747-06284E272751Q35533394-8103DC94-764D-4313-8BCC-2E5B1FD20D58Q35607603-6B82FFDA-EE1D-4F47-A97A-7B3427E40F9AQ35662823-B9817398-815B-4B8A-91FE-6CB3CC8F8930Q36221294-3258DDE8-6F33-4E26-86A4-0349A06C64FDQ36986264-76F357AA-44F9-4378-8B35-2AF782457690Q38087680-CEC4A528-BF22-4E71-AC02-311016C918F8Q38478863-165E2F70-2631-4B36-9006-8274F6096832Q38552059-071E3C9D-E32C-4D41-AAA1-DAE32048698FQ38968676-62B397DA-20F8-4AC6-A84F-39BC93D713C8Q39193693-FBE71DF8-CB0E-4A73-97CD-6C81A342DEDFQ42771112-D0ED4D61-13DD-4D2C-9D05-35E93364794CQ47586716-2BF11571-0832-4BF5-ADA9-CEED6E5F19B2Q47901480-B885BB72-6531-4753-BB27-363FAEE16516
P2860
Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@ast
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@en
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@nl
type
label
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@ast
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@en
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@nl
prefLabel
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@ast
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@en
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@nl
P2093
P2860
P1433
P1476
Cytochrome b5 and cytokeratin ...... ing onset of acute lung injury
@en
P2093
Anthony T Vella
Antoine Ménoret
Sanjeev Kumar
P2860
P304
P356
10.1371/JOURNAL.PONE.0040184
P407
P577
2012-01-01T00:00:00Z